Abstract:Transforming growth factor-β (TGF-β) is a secreted multifunctional factor that plays a key role in intercellular communication. Perturbations of TGF-β signaling can lead to breast cancer. TGF-β elicits its effects on proliferation and differentiation via specific cell surface TGF-β type I and type II receptors (i.e., TβRI and TβRII) that contain an intrinsic serine/threonine kinase domain. Upon TGF-β-induced heteromeric complex formation, activated TβRI elicits intracellular signaling by phosphorylating SMAD2 and SMAD3. These activated SMADs form heteromeric complexes with SMAD4 to regulate specific target genes, including plasminogen activation inhibitor 1 (PAI-1, encoded by the SERPINE1 gene). The induction of epithelial-to-mesenchymal transition (EMT) allows epithelial cancer cells at the primary site or during colonization at distant sites to gain an invasive phenotype and drive tumor progression. TGF-β acts as a potent inducer of breast cancer invasion by driving EMT. Here, we describe systematic methods to investigate TGF-β signaling and EMT responses using premalignant human MCF10A-RAS (M2) cells and mouse NMuMG epithelial cells as examples. We describe methods to determine TGF-β-induced SMAD2 phosphorylation by Western blotting, SMAD3/SMAD4-dependent transcriptional activity using luciferase reporter activity and SERPINE1 target gene expression by quantitative real-time-polymerase chain reaction (qRT-PCR). In addition, methods are described to examine TGF-β-induced EMT by measuring changes in morphology, epithelial and mesenchymal marker expression, filamentous actin staining and immunofluorescence staining of E-cadherin. Two selective small molecule TGF-β receptor kinase inhibitors, GW788388 and SB431542, were used to block TGF-β-induced SMAD2 phosphorylation, target genes and changes in EMT marker expression. Moreover, we describe the transdifferentiation of mesenchymal breast Py2T murine epithelial tumor cells into adipocytes. Methods to examine TGF-β-induced signaling and EMT in breast cancer may contribute to new therapeutic approaches for breast cancer.

TGF-β Signaling in Endothelial-to-Mesenchymal Transition: the Role of Shear Stress and Primary CiliaA Presentation from the Keystone Symposium on Epithelial Plasticity and Epithelial to Mesenchymal Transition, Vancouver, Canada, 21 to 26 January 2011.

TGF-β signaling in endothelial-to-mesenchymal transition: the role of shear stress and primary cilia.

Lack of Primary Cilia Primes Shear-Induced Endothelial-to-Mesenchymal Transition

Shear Stress Modulates TGF‐beta Signaling and EMT in Endothelial Cells

Tgfβ/Alk5 Signaling is Required for Shear Stress Induced Klf2 Expression in Embryonic Endothelial Cells.

Regulation of Endothelial Cell Plasticity by TGF-β

The role of shear-induced transforming growth factor-β signaling in the endothelium

Regulation Of Endothelial Cell Plasticity By Tgf-Beta

Shear Stress Initiates Endothelial to Mesenchymal Transition in Endocardial Endothelial Cells

Visualizing Dynamic Changes During TGF-β-Induced Epithelial to Mesenchymal Transition.

Fluid Shear Stress-Induced TGF-β/ALK5 Signaling in Renal Epithelial Cells is Modulated by MEK1/2

TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering

Shear stress induces endothelial-to-mesenchymal transition via the transcription factor Snail

Extracellular matrix as a contextual determinant of transforming growth factor-β signaling in epithelial-mesenchymal transition and in cancer

Endocardial primary cilia and blood flow are required for regulation of EndoMT during endocardial cushion development

Primary Cilia and Atherosclerosis

TGF-β Signaling and Vascular Morphogenesis

Comprehensive transcriptome analysis of fluid shear stress altered gene expression in renal epithelial cells

TGF-β Signaling Mediates Endothelial-to-Mesenchymal Transition (EndMT) During Vein Graft Remodeling

Pdgf-Bb And Tgf-Beta 1 On Cross-Talk Between Endothelial And Smooth Muscle Cells In Vascular Remodeling Induced By Low Shear Stress

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells.